Trevi Therapeutics
TRVI
#4872
Rank
NZ$3.71 B
Marketcap
NZ$26.04
Share price
-0.40%
Change (1 day)
78.77%
Change (1 year)

Earnings for Trevi Therapeutics (TRVI)

Earnings in 2026 (TTM): -NZ$80.91 Million

According to Trevi Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$76.86 Million, an increase over its 2024 earnings that were of -NZ$83.85 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevi Therapeutics from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$80.91 Million5.27%
2025 -NZ$76.86 Million-8.34%
2024 -NZ$83.85 Million67%
2023 -NZ$50.21 Million2.43%
2022 -NZ$49.02 Million-14.45%
2021 -NZ$57.3 Million1.36%
2020 -NZ$56.54 Million23.64%
2019 -NZ$45.73 Million27.54%
2018 -NZ$35.85 Million